InsightPharmaReports com
This report reviews the role of CER intelligence, the significant gaps it has identified in physician knowledge and how CER information will shape the way that pharmaceutical firms promote their products. Based on expert interviews and the latest research, the report reveals the key factors influencing physician decisions, from formal education, casual colleague conversations, insurance regulations and government subsidies to continuing medical education, samples and even patient pressure.
Key features:
• Compelling insight into how pharma can address prescribing trends
• Examination of CERs influence on pharma, patient care and academic detailing
• Expert insight into how new drug promotions can evolve
• Discussion of how promotions can impact doctor-patient relations
• Analysis of why some drugs are overprescribed while others are underutilized
• Charts and tables illustrating compliance, prescribing trends
For more information and to purchase this Insight Pharma Report, visit: http://www.InsightPharmaReports.com
About Insight Pharma Reports
Insight Pharma Reports are written by experts in consulting and industry who collaborate with us to provide a series of reports that evaluate the salient issues in pharmaceutical technology, business, and therapy markets. Insight Pharma Reports are used by leading pharmaceutical, biotech, diagnostic, consulting, and financial companies to keep abreast of the latest advances in pharmaceutical R&D, their potential applications and business impacts, and their current and future position in the marketplace. Insight Pharma Reports is a division within Cambridge Healthtech Institute. http://www.InsightPharmaReports.com
Insight Pharma Reports offers our Affiliated Reports Collection which provides a repository of additional scientific and business resources. For more information, visit http://www.insightpharmareports.com/
# # #
Insight Pharma Reports are written by experts in consulting and industry who collaborate with us to provide a series of reports that evaluate the salient issues in pharmaceutical technology, business, and therapy markets.
Photo:
http://www.prlog.org/
